Keyphrases
Prostate Cancer
100%
ERK5
100%
Aberrant Expression
100%
Tumor
25%
Extracellular Signal-regulated Kinase
16%
MEK5
16%
PC-3 Cells
16%
Aggressive Prostate Cancer
16%
Overexpression
8%
Overexpressing
8%
Protein Expression
8%
Mitogen
8%
ERK2
8%
Intracellular Signaling
8%
Oncogenesis
8%
Nuclear Localization
8%
Immunoreactivity
8%
Weak Association
8%
LNCaP
8%
High Dose
8%
P Factor
8%
Co-transfection
8%
Clinical Disease
8%
Working Diagnosis
8%
Specific Substrate
8%
Novel Therapeutic Targets
8%
In Vivo Evidence
8%
Locally Advanced Disease
8%
Expression Data
8%
Androgen-independent
8%
Benign Prostatic Hyperplasia
8%
Bony Metastasis
8%
High-grade Prostate Cancer
8%
MEK1 Inhibitor
8%
Multivariant Analysis
8%
Independent Prognostic Factor
8%
Invasive Ability
8%
Gleason Sum
8%
Nuclear Expression
8%
PD184352
8%
MAPK Substrate
8%
Disease-specific Survival
8%
Biochemistry, Genetics and Molecular Biology
Extracellular Signal-Regulated Kinases
100%
Carcinogenesis
33%
Mitogen-Activated Protein Kinase
33%
Protein Expression
33%
Phosphotransferase
33%
Kinase
33%
Intracellular Signaling
33%
Low Drug Dose
33%
Drug Megadose
33%
Immunoreactivity
33%
LNCaP
33%
Gleason Score
33%
Disease Specific Survival
33%
Medicine and Dentistry
Prostate Cancer
100%
Mitogen Activated Protein Kinase 7
100%
Neoplasm
25%
Disease
25%
Mitogen-Activated Protein Kinase
25%
In Vitro
16%
Metastatic Carcinoma
8%
Carcinogenesis
8%
Drug Megadose
8%
Low Drug Dose
8%
Phosphotransferase
8%
Protein Expression
8%
Immunoreactivity
8%
Androgen
8%
Mitogen Activated Protein Kinase 3
8%
Intracellular Signaling
8%
Prognostic Factor
8%
Mitogenic Agent
8%
Gleason Score
8%
Prostate Hypertrophy
8%
Disease Specific Survival
8%
2 (2 Chloro 4 Iodoanilino) N Cyclopropylmethoxy 3,4 Difluorobenzamide
8%
Neuroscience
Prostate
100%
Extracellular Signal-Regulated Kinases
100%
Mitogen Activated Protein Kinase 7
100%
In Vivo
18%
In Vitro
18%
Mitogen-Activated Protein Kinase
9%
Protein Expression
9%
Mitogen Activated Protein Kinase 3
9%
Kinase
9%
Carcinogenesis
9%
Intracellular Signaling
9%
Hyperplasia
9%
Androgen
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Mitogen Activated Protein Kinase 7
100%
Neoplasm
25%
Disease
25%
Mitogen Activated Protein Kinase
16%
Carcinogenesis
8%
Phosphotransferase
8%
Mitogen Activated Protein Kinase 3
8%
Mitogenic Agent
8%
Androgen
8%
2 (2 Chloro 4 Iodoanilino) N Cyclopropylmethoxy 3,4 Difluorobenzamide
8%
Disease Specific Survival
8%
Gleason Score
8%
Prostate Hypertrophy
8%